BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1379391)

  • 1. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Chong P; Tripet B; Brush B; Gillam S
    Virology; 1992 Aug; 189(2):483-92. PubMed ID: 1379391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.
    Trudel M; Nadon F; Séguin C; Amarouch A; Payment P; Gillam S
    J Virol Methods; 1985 Dec; 12(3-4):243-50. PubMed ID: 2422194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.
    Wolinsky JS; Sukholutsky E; Moore WT; Lovett A; McCarthy M; Adame B
    J Virol; 1993 Feb; 67(2):961-8. PubMed ID: 7678312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.
    Wolinsky JS; McCarthy M; Allen-Cannady O; Moore WT; Jin R; Cao SN; Lovett A; Simmons D
    J Virol; 1991 Aug; 65(8):3986-94. PubMed ID: 1712855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells.
    Cordoba P; Grutadauria S; Cuffini C; Zapata M
    Viral Immunol; 2000; 13(1):83-92. PubMed ID: 10733171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies directed to E1 glycoprotein of rubella virus.
    Umino Y; Sato TA; Katow S; Matsuno T; Sugiura A
    Arch Virol; 1985; 83(1-2):33-42. PubMed ID: 2578781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping T-cell epitopes of rubella virus structural proteins E1, E2, and C recognized by T-cell lines and clones derived from infected and immunized populations.
    Ou D; Chong P; Tingle AJ; Gillam S
    J Med Virol; 1993 Jul; 40(3):175-83. PubMed ID: 7689090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the rubella E1 epitopes.
    Terry GM; Ho-Terry L; Londesborough P; Rees KR
    Arch Virol; 1988; 98(3-4):189-97. PubMed ID: 2450528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.
    McCarthy M; Lovett A; Kerman RH; Overstreet A; Wolinsky JS
    J Virol; 1993 Feb; 67(2):673-81. PubMed ID: 7678302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of three minimal T helper cell epitopes of rubella virus E1 glycoprotein.
    Marttila J; Ilonen J; Lehtinen M; Parkkonen P; Salmi A
    Clin Exp Immunol; 1996 Jun; 104(3):394-7. PubMed ID: 9099921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity.
    Giessauf A; Letschka T; Walder G; Dierich MP; Würzner R
    J Immunol Methods; 2004 Apr; 287(1-2):1-11. PubMed ID: 15099751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia.
    van Rijn PA; van Gennip HG; de Meijer EJ; Moormann RJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2053-60. PubMed ID: 7691986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Ou D; Chong P; Gillam S
    J Clin Immunol; 1993 Mar; 13(2):93-100. PubMed ID: 8320313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R237 and h238 are key amino acids in the rubella virus E1 neutralization epitope.
    Li ZM; Chu FL; Wen HL; Sun ZH; Li GH; Xie WY; Wang ZY
    Viral Immunol; 2014 Nov; 27(9):422-9. PubMed ID: 25226223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immunoreactive regions of rubella virus E1 and E2 envelope proteins by using synthetic peptides.
    Mitchell LA; Décarie D; Tingle AJ; Zrein M; Lacroix M
    Virus Res; 1993 Jul; 29(1):33-57. PubMed ID: 7692685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of synthetic peptides with sequences of rubella virus E1 polypeptide by antibodies and T lymphocytes.
    Ilonen J; Seppänen H; Närvänen A; Korkolainen M; Salmi AA
    Viral Immunol; 1992; 5(3):221-8. PubMed ID: 1384533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence variation and biological activity of rubella virus isolates.
    Londesborough P; Ho-Terry L; Terry G
    Arch Virol; 1995; 140(3):563-70. PubMed ID: 7537491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.
    Green KY; Dorsett PH
    J Virol; 1986 Mar; 57(3):893-8. PubMed ID: 2419590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition.
    Ou D; Mitchell LA; Ho M; Dćarie D; Tingle AJ; Nepom GT; Lacroix M; Zrein M
    Hum Immunol; 1994 Mar; 39(3):177-87. PubMed ID: 7517931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.